End-of-day quote
Taiwan S.E.
03:30:00 07/05/2024 am IST
|
5-day change
|
1st Jan Change
|
9.04
TWD
|
-1.20%
|
|
+0.78%
|
-0.99%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
6,609
|
7,153
|
10,433
|
11,185
|
8,808
|
9,191
|
Enterprise Value (EV)
1 |
9,990
|
9,507
|
7,117
|
7,584
|
6,001
|
5,292
|
P/E ratio
|
25
x
|
401
x
|
6.19
x
|
15.5
x
|
23.7
x
|
15.5
x
|
Yield
|
2.31%
|
-
|
6.73%
|
3.77%
|
1.14%
|
-
|
Capitalization / Revenue
|
0.22
x
|
0.26
x
|
0.4
x
|
0.55
x
|
0.39
x
|
0.45
x
|
EV / Revenue
|
0.33
x
|
0.35
x
|
0.28
x
|
0.38
x
|
0.27
x
|
0.26
x
|
EV / EBITDA
|
7.45
x
|
6.68
x
|
1.72
x
|
3.42
x
|
4.76
x
|
4.15
x
|
EV / FCF
|
23.5
x
|
3.74
x
|
1.31
x
|
6.62
x
|
-21.3
x
|
5.78
x
|
FCF Yield
|
4.26%
|
26.7%
|
76.6%
|
15.1%
|
-4.69%
|
17.3%
|
Price to Book
|
0.59
x
|
0.68
x
|
0.85
x
|
0.89
x
|
0.72
x
|
0.76
x
|
Nbr of stocks (in thousands)
|
10,16,825
|
10,03,165
|
10,03,165
|
10,03,165
|
10,06,683
|
10,06,683
|
Reference price
2 |
6.500
|
7.130
|
10.40
|
11.15
|
8.750
|
9.130
|
Announcement Date
|
29/03/19
|
31/03/20
|
26/03/21
|
16/03/22
|
16/03/23
|
14/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
30,394
|
27,460
|
25,849
|
20,211
|
22,644
|
20,292
|
EBITDA
1 |
1,341
|
1,423
|
4,147
|
2,216
|
1,259
|
1,275
|
EBIT
1 |
748.2
|
860
|
3,633
|
1,782
|
796.9
|
770
|
Operating Margin
|
2.46%
|
3.13%
|
14.06%
|
8.82%
|
3.52%
|
3.79%
|
Earnings before Tax (EBT)
1 |
670.4
|
566
|
3,010
|
1,991
|
899.9
|
1,051
|
Net income
1 |
263.8
|
17.82
|
1,686
|
722.7
|
370.2
|
599.1
|
Net margin
|
0.87%
|
0.06%
|
6.52%
|
3.58%
|
1.63%
|
2.95%
|
EPS
2 |
0.2600
|
0.0178
|
1.680
|
0.7200
|
0.3685
|
0.5900
|
Free Cash Flow
1 |
425.2
|
2,539
|
5,450
|
1,145
|
-281.5
|
916.2
|
FCF margin
|
1.4%
|
9.25%
|
21.08%
|
5.67%
|
-1.24%
|
4.51%
|
FCF Conversion (EBITDA)
|
31.7%
|
178.37%
|
131.4%
|
51.68%
|
-
|
71.88%
|
FCF Conversion (Net income)
|
161.16%
|
14,248.07%
|
323.14%
|
158.45%
|
-
|
152.93%
|
Dividend per Share
2 |
0.1500
|
-
|
0.7000
|
0.4200
|
0.1000
|
-
|
Announcement Date
|
29/03/19
|
31/03/20
|
26/03/21
|
16/03/22
|
16/03/23
|
14/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
3,381
|
2,354
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
3,316
|
3,602
|
2,808
|
3,899
|
Leverage (Debt/EBITDA)
|
2.52
x
|
1.654
x
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
425
|
2,539
|
5,450
|
1,145
|
-281
|
916
|
ROE (net income / shareholders' equity)
|
3.01%
|
2.53%
|
15.9%
|
8.85%
|
3.94%
|
5.4%
|
ROA (Net income/ Total Assets)
|
1.79%
|
2.18%
|
9.45%
|
4.61%
|
2.12%
|
2.11%
|
Assets
1 |
14,755
|
815.7
|
17,848
|
15,667
|
17,488
|
28,410
|
Book Value Per Share
2 |
11.00
|
10.40
|
12.30
|
12.60
|
12.10
|
12.10
|
Cash Flow per Share
2 |
3.190
|
3.190
|
6.550
|
6.420
|
5.380
|
6.480
|
Capex
1 |
171
|
400
|
188
|
752
|
466
|
357
|
Capex / Sales
|
0.56%
|
1.46%
|
0.73%
|
3.72%
|
2.06%
|
1.76%
|
Announcement Date
|
29/03/19
|
31/03/20
|
26/03/21
|
16/03/22
|
16/03/23
|
14/03/24
|
|
1st Jan change
|
Capi.
|
---|
| -0.99% | 285M | | +4.46% | 102B | | -2.28% | 65.27B | | +46.19% | 41.44B | | +19.71% | 40.05B | | +4.80% | 32.48B | | +11.55% | 19.71B | | +17.06% | 17.33B | | +20.73% | 15.6B | | +11.59% | 15.34B |
Other Commodity Chemicals
|